Global Immunochemicals Market to Reach $3.6 Billion by 2017, According to a New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive global report on the Immunochemicals markets. Driven by significant advancements in the field of antibody technology, and developments associated with proteome research and Human Genome Project, the global immunochemicals market is projected to reach $3.6 billion by the year 2017.

Immunochemicals: A Global Strategic Business Report

The global immunochemicals market is witnessing robust growth due to increase in demand from counter bio-terrorism, healthcare and agriculture sectors. Increase in research efforts for enhancing food nutrition and quality, improving food production as well as producing industrial and pharmaceutical products through genetically engineered plants is also fuelling the demand for immunochemicals. The immunochemicals market is also focusing on the development of antibody assays for anthrax, cholera toxin, and diphtheria toxin for use in law enforcement settings.

The United States and Europe dominate the global immunochemicals market, as stated by the new market research report on Immunochemicals. The immunochemicals markets in China, Australia, and India, though relatively small, are expected to grow rapidly owing to the increasing emphasis on biotechnology sector, which is in turn contributing to the increased demand for research antibodies. Active government support for biotechnology research and emergence of India and China as major centers of clinical research are also favoring the growth of immunochemicals market in the region. The widespread availability of infrastructure facilities and low-cost workforce is fostering growth in the clinical research organization (CRO) market, which is in turn offering enhanced prospects in the regions’ immunochemicals market. China represents the fastest growing region in the global immunochemicals market.

Continuous rise in the number of suppliers as well as the availability of a broad range of antibodies has been favoring growth in the catalog antibody market. Catalog antibodies, pre-made polyclonal and monoclonal antibodies manufactured from a variety of host species, find use in all spheres of drug discovery and biological research. The United States represents the single largest market for catalog antibodies. The focus has shifted from catalog antibodies towards custom antibodies, owing to the advent of proteomics and identification of newer targets. Genome projects and proteome research are creating growth opportunities for custom antibodies by facilitating discovery of novel proteins, thereby encouraging manufacturers to augment and revamp their stocks with novel antibodies. The preference for custom antibodies continues to grow, despite their higher price in comparison to catalogue antibodies. The higher cost also implies that custom antibodies are preferred primarily among researchers with adequate funds.

The global immunochemicals market is an evolving and dynamic market, and is characterized by high degree of fragmentation and intense competition. The market participants include pharmaceutical and biotech companies, antibody manufacturers, and diagnostic companies, while academic researchers and scientific community from biotechnology and pharmaceutical industries are major end-user groups. Select players profiled in the report include Advanced ImmunoChemical, Beckman Coulter Inc., BIOTREND Chemikalien GmbH, Bio-Rad Laboratories Inc., Maine Biotechnology Services, Meridian Life Science® Inc., Millipore Corporation, MitoSciences Inc., Randox Laboratories Ltd., Roche Group, Rockland Immunochemicals, Sigma-Aldrich Co, and Trinity Biotech PLC.

The research report titled “Immunochemicals: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a review of the immunochemicals market, recent product launches, strategic corporate initiatives, and profiles of major market participants. The report provides annual sales estimates and projections for Immunochemicals market for the geographic markets - US, Canada, Japan, Europe, China, and Rest of World. Key segments analyzed include Catalog Antibodies and Custom Antibodies.

For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Immunochemicals_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1200 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
E-mail: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website

Media